Precision Business Insights
Portfolio

 

Lung Preservation Systems Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Lung Preservation Systems Market By Preservation Technique (Hypothermic Perfusion Preservation (HPP), Static Cold Storage (SCS), Others), By Preservation Solution (Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution, Human Biosystem (HBS) Solution, Renograf, Viaspen, Lifor, Perfadex, Others), By End User (Hospitals, Clinics, Others), and Geography

 

Market Outline: Global Lung Preservation Systems Market

Lung preservation is the process of protecting and maintaining the donor lung from lung procurement up to the implantation in the desired recipients. Perfusion volume and pressure, temperature, oxygenation, and degree of inflation are the key factors impact the lung injury during the preservation or at the time of preservation, and lung function after the transplantation to recipients. Lung procurement is usually performed after the brain death or cardiac death of the patients.

 

Global lung preservation systems market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024.

 

Market Dynamics: Global Lung Preservation Systems Market

Increase in the number of brain death cases due to rise in number of accidents and traumatic injuries is a key factor drives the global market. Moreover, increase in the awareness about the organ donation among the people, government initiations for the organ transplantation procedures, sophisticated healthcare infrastructure in the developed countries, rise in R&D expenditure for the development of newer methods for lungs storage, and favorable reimbursement policies are anticipated to spur the global market over the forecast period. However, high cost of procedure, dearth of skilled persons in underdeveloped regions, and limited scope at the end user level are hinder the growth of global lung preservation systems market.

 

Market Scope

Global lung preservation systems market is segmented based on preservation technique, preservation solution, and end user

 

Based on preservation technique, market is segmented into the following:

  • Hypothermic Perfusion Preservation (HPP)
  • Static Cold Storage (SCS)
  • Others

Based on preservation solution, market is segmented into the following

  • Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution
  • Human Biosystem (HBS) Solution
  • Renograf
  • Viaspen
  • Lifor
  • Perfadex
  • Others

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Clinics
  • Others

 

Geography

 

 North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

 

Regional Analysis: Global Lung Preservation Systems Market

Geographically, global lung preservation systems market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America market is poised to grow due to rise in lung transplantation procedures in U.S. and Canada, rise in consumption of tobacco and alcohol results to lung failure, and well developed healthcare infrastructure are propel the market. Europe market has prominent share attributed to increase in the recipients for lung transplantation for instance, according to European Commission 2014, approximately 2,100 lung recipients are in the waiting list, rise in healthcare expenditure, and presence of skilled professionals are boost the market. However, Asia Pacific  market is driving by rise in medical tourism in Asia Pacific countries for organ transplantation, rise in awareness about the organ donation among the people, and entry of market players into Asia Pacific region are bolster the market.

 

Competition Assessment

  • Franz Kohler Chemie GmbH (Germany)
  • Organ Recovery Systems (U.S.)
  • Waters Medical Systems LLC (U.S.)
  • Essential Pharmaceuticals LLC (U.S.)
  • Xvivo Perfusion AB (Sweden)
  • BioLife Solutions, Inc. (U.S.)
  • Preservation Solutions, Inc. (U.S.)
  • Transmedics, Inc. (U.S.)
  • CryoLife, Inc. (U.S.)

Notable Market Developments

  • In April 2018, transmedics received FDA approval to launch its Organ Care System (OCS) Lung for use in standard double lung transplant procedures
    
$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials